The Biocidal Products Regulation (BPR, Regulation (EU) 528/2012) concerns the placing on the market and use of biocidal products.
These are used to protect humans, animals, materials or articles against harmful organisms like pests or bacteria, by the action of the active substances contained in the biocidal product. The BPR repeals the Biocidal Products Directive (Directive 98/8/EC).
All biocidal products require an authorisation before they can be placed on the market, and the active substances contained in that biocidal product must be previously approved. There are some exceptions to this rule. The goal of the BPR is to simplify the approval of active substances and authorisation of biocidal products. It also introduces specific timelines for the Authorities.
If you would like to talk to a member of H2 Compliance about your requirements please call us today on +353 1 2989136 (for Cork office +353 21 4868120, or New York office +1 518 5123553) or email us at email@example.com.
Alternatively you can use our enquiry form here and a member of our team will be in touch ASAP.
As with REACH, it promotes the reduction of animal testing through mandatory data sharing obligations and the use of alternative testing methods. The approval of active substances takes place at EU level and the subsequent authorisation of the biocidal products at Member State level.
H2 Compliance offers a broad range of services to Clients wishing to place biocidal products on the EU Market including:
- Active Substance Authorisation
- Biocidal Product Authorisation
- Treated Articles